e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Management of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
On abandon of the tuberculosis treatment
M. M. Panescu, C. C. Vasilescu, M. M. Archip (Iasi, Romania)
Source:
Annual Congress 2003 - Management of tuberculosis
Session:
Management of tuberculosis
Session type:
Thematic Poster Session
Number:
3255
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. M. Panescu, C. C. Vasilescu, M. M. Archip (Iasi, Romania). On abandon of the tuberculosis treatment. Eur Respir J 2003; 22: Suppl. 45, 3255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Rimfampicin importance in tuberculosis treatment
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Has the time come to shorten TB treatment and TB preventive therapy?
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Re-think first-line tuberculosis treatment
Source: Eur Respir J 2013; 41: 488-489
Year: 2013
How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take?
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
A new era for treatment of drug-resistant tuberculosis
Source: Eur Respir J, 52 (4) 1801350; 10.1183/13993003.01350-2018
Year: 2018
Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous?
Source: Eur Respir J 2011; 37: 1283-1285
Year: 2011
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity?
Source: Eur Respir J, 49 (5) 1700738; 10.1183/13993003.00738-2017
Year: 2017
Diaskintest at patients after successful treatment of lung tuberculosis
Source: International Congress 2017 – Migrants and screening
Year: 2017
The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis
Source: Eur Respir J, 55 (3) 2000224; 10.1183/13993003.00224-2020
Year: 2020
Experience of isofon use for therapy and chemoprophylaxis of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004
Effect on treatment of giving information about tuberculosis to the tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 644s
Year: 2005
Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
The causes of ineffectiveness of treatment of tuberculosis in children
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept